COMPOSTOS DE QUINOLINA E QUINAZOLINA UTEIS EM TERAPEUTICA PARTICULARMENTE NO TRATAMENTO DA HIPERPLASIA PROSTATICA BENIGNA

Compounds of formula I,whereinR1 represents C1-4 alkoxy optionally substituted by one or more fluorine atoms;R2 represents H or C1-4 alkoxy optionally substituted by one or more fluorine atoms;R3 represents a 5- or 6-membered heterocyclic ring, the ring being optionally substituted;R4 represents a 4...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: DAVID NATHAN ABRAHAM FOX
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds of formula I,whereinR1 represents C1-4 alkoxy optionally substituted by one or more fluorine atoms;R2 represents H or C1-4 alkoxy optionally substituted by one or more fluorine atoms;R3 represents a 5- or 6-membered heterocyclic ring, the ring being optionally substituted;R4 represents a 4-, 5-, 6-, or 7-membered heterocyclic ring, the ring being optionally fused to a benzene ring or a 5- or 6-membered heterocyclic ring, the ring system as a whole being optionally substituted;X represents CH or N; andL is absent, or represents a cyclic group of formula Ia, or represents a chain of formula Ib,and pharmaceutically acceptable salts thereof; are useful in therapy, in particular in the treatment of benign prostatic hyperplasia.